Home VitaDX

VitaDX

VitaDX

VitaDX
Category
Business Description
This technology, based on research carried out by researchers from the Institute of Molecular Sciences in Orsay (ISMO, UMR CNRS and Université Paris-Sud) and practitioners at CHU Bicêtre (AP-HP), aims to diagnose bladder cancer earlier and more reliably.
VitaDX started its first clincal trial in january 2017 and obtained the CE marking for its first.
VitaDX is currently developing a medical software solution for early diagnosis of bladder cancer using fluorescence imaging and machine learning.
Based in
Paris
Tags
Biotechnology,Medical Device,Biotechnology, Hospital, Medical
Total Funding
Between €2.5 million-5 million
Founded
2014
Website
http://vitadx.com/en/
💡 You're a corporate or investor and looking for startups that are innovating in the same market as VitaDX? We're happy to assist you with our Startup Sourcing service.